黄芪四君子汤联合罗格列酮治疗 2 型 糖尿病对患者糖脂代谢的影响
CSTR:
作者:
作者单位:

(焦作市人民医院,河南 焦作 4540002)

作者简介:

王雅雯,女,主管药师,主要研究方向是医院药学。

通讯作者:

中图分类号:

R 587.1

基金项目:


Effect of Huangqi Sijunzi Decoction Combined with Rosiglitazone on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes
Author:
Affiliation:

(Jiaozuo People's Hospital Henan Jiaozuo 4540002)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:探讨黄芪四君子汤加减联合罗格列酮治疗对 2 型糖尿病患者的应用效果。方法:回顾焦作市人民医院 2016 年 2 月至 2019 年 2 月期间收治的 80 例 2 型糖尿病患者,根据治疗方法不同分为对照组(罗格列酮治疗,40 例)与观 察组(黄芪四君子汤加减联合罗格列酮治疗,40 例),比较两组治疗效果。结果:治疗前两组患者的血糖水平比较,差异 无统计学意义(P > 0.05);治疗后两组患者的血糖水平均有不同程度改善,且观察组改善程度大于对照组,差异具有统 计学意义(P < 0.05)。治疗前两组患者的血脂水平比较,差异无统计学意义(P > 0.05);治疗后两组患者的血脂水平均 有不同程度改善,且观察组改善程度大于对照组,差异具有统计学意义(P < 0.05)。结论:黄芪四君子汤加减联合罗格 列酮治疗,可调节 2 型糖尿病患者的糖脂代谢,具有降糖降脂的作用。

    Abstract:

    〔Abstract〕 Objective To explore the application effect of Huangqi Sijunzi decoction combined with rosiglitazone treatment on patients with type 2 diabetes. Methods A review of 80 patients with type 2 diabetes who were admitted to Jiaozuo People’s Hospital from February 2016 to February 2019. According to different treatment Methods, they were divided into a control group (rosiglitazone treatment, 40 cases) and an observation group (Huangqi Sijunzi Decoction combined with rosiglitazone treatment, 40 cases), the treatment effects of the two groups were compared. Results There was no statistically significant difference in blood glucose levels between the two groups of patients before treatment (P > 0.05). After treatment, the blood glucose levels of the two groups of patients were improved to different degrees, and the improvement of the observation group was greater than that of the control group, the difference was statistically significant (P < 0.05); the comparison of the blood lipid levels of the two groups of patients before treatment was not statistically significant (P > 0.05). After treatment, the blood lipid levels of the two groups were improved to different degrees, and the improvement degrees of the observation group were greater than those of the control group, the differences were statistically significant (P < 0.05). Conclusion Huangqi Sijunzi decoction combined with rosiglitazone treatment can regulate the glucose and lipid metabolism of patients with type 2 diabetes, and has the effect of reducing blood sugar and lipids.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-06-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-18
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭